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a  b  s  t  r  a  c  t
Chronic  alcohol  abuse  is a systemic  disorder  and a risk  factor for  acute  respiratory  distress  syndrome
(ARDS)  and  chronic  obstructive  pulmonary  disease  (COPD).  A  signiﬁcant  amount  of  ingested  alcohol
reaches  airway  passages  in the  lungs  and can  be metabolized  via  oxidative  and  non-oxidative  pathways.
About  90%  of  the  ingested  alcohol  is  metabolized  via  hepatic  alcohol  dehydrogenase  (ADH)-catalyzed
oxidative  pathway.  Alcohol  can also be metabolized  by  cytochrome  P450  2E1  (CYP2E1),  particularly  dur-
ing  chronic  alcohol  abuse.  Both  the  oxidative  pathways,  however,  are  associated  with  oxidative  stress  due
to the  formation  of acetaldehyde  and/or  reactive  oxygen  species  (ROS).  Alcohol  ingestion  is  also  known
to  cause  endoplasmic  reticulum  (ER)  stress,  which  can  be mediated  by  oxidative  and/or  non-oxidative
metabolites  of ethanol.  An acute  as  well  as chronic  alcohol  ingestions  impair  protective  antioxidants,  oxi-
dize reduced  glutathione  (GSH,  cellular  antioxidant  against  ROS and  oxidative  stress),  and  suppress  innate
and adaptive  immunity  in the  lungs.  Oxidative  stress  and suppressed  immunity  in the  lungs  of  chronic
alcohol  abusers  collectively  are considered  to be  major  risk  factors  for infection  and  development  of  pneu-
monia,  and  such  diseases  as ARDS  and  COPD.  Prior  human  and  experimental  studies  attempted  to  identify
common  mechanisms  by which  alcohol  abuse  directly  causes  toxicity  to alveolar  epithelium  and  respira-
tory  tract,  particularly  lungs.  In  this review,  the  metabolic  basis  of lung  injury,  oxidative  and  ER  stress  and
immunosuppression  in  experimental  models  and  alcoholic  patients,  as  well  as potential  immunomodu-
latory  therapeutic  strategies  for  improving  host defenses  against  alcohol-induced  pulmonary  infections
are  discussed.© 2013 The A
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. Introduction
Chronic alcohol abuse or alcoholism cost ∼$223 billion to US
conomy and 79,000 deaths each year (Bouchery et al., 2011). The
orldwide death toll is estimated to be ∼30-fold greater than that
n the US (CDC, 2004; NIAAA, 2000). Approximately 10–20 mil-
ion people meet the criteria of alcoholic dependence in the United
tates and >500 million worldwide (Grant et al., 2004; Lieber, 1995).
lcohol over consumption damages almost every organ in the body
nd predisposes the host to a wide range of infectious diseases
uch as pneumonia, acute respiratory distress syndrome (ARDS)
nd chronic obstructive pulmonary disease (COPD) (Liang et al.,
012; Pabst et al., 2011; Zhang et al., 2002a). Therefore, chronic
lcohol abuse is a major health issue worldwide.
Although ingested alcohol is mainly metabolized in the liver,
 sizable amount of the dose reaches the airway passages by the
ronchial circulation and is metabolized via oxidative and/or non-
xidative pathways (Manautou et al., 1992; Manautou and Carlson,
991). Some of this alcohol may  be excreted unchanged in exhaled
reath. Alcohol consumption compromises systemic immunity,
hereby increasing the susceptibility of the host to pulmonary
nfections characterized by severe symptoms, and less favorable
utcomes such as ARDS and COPD (Liang et al., 2012; Moss et al.,
996; Pabst et al., 2011). Both, ARDS and COPD in chronic alco-
ol abusers result in hospitalization, extensive treatment cost and
igniﬁcant mortalities. Therefore, alcohol abuse is a systemic disor-
er with speciﬁc effects on the respiratory system associated with
ncreased incidence of infections in the lung (Gamble et al., 2006;
hellito, 1998; Vander Top et al., 2005). In this review, we sum-
arize current understanding of ethanol metabolism in the lungs
nd its consequential oxidative stress and ER stress, suppression
f innate and adaptive immunity of the lungs. Finally, we review
herapeutic strategies used to mitigate immunosuppression and
xidative stress.
. Metabolism of alcohol in the lungs
The majority of ingested ethanol is metabolized in the liver
y cytosolic alcohol dehydrogenase (ADH) to acetaldehyde, which
s further oxidized by mitochondrial aldehyde dehydrogenase
ALDH) to acetate (Lieber, 2004). Mammalian lungs can metabo-
ize ingested ethanol by ADH followed by ALDH at rates dependent
n its concentration (Bernstein, 1982; Jones, 1995; Qin and Meng,
006; Vasiliou and Marselos, 1989; Yin et al., 1992). Ethanol can also
e metabolized by microsomal cytochrome P450 2E1 (CYP2E1) and
be an important enzyme for ethanol oxidative metabolism due to
its inhibition by ethanol (Das and Mukherjee, 2010). Mammalian
lung parenchyma consist of large squamous alveolar type I epithe-
lial cells (8% of the cells, but one of the largest cells and cover
∼97% of alveolar space area), alveolar type II cells (16% of the total
alveolar cells, half that of the type I pneumocyte), capillary endothe-
lial cells (30% of the lung cells) and variable number of alveolar
macrophages. Cells in the interstitial space comprised of 37% of
the total cells (Matalon, 1991). Whether all cell types in the lungs
metabolize ethanol is very poorly studied. Bronchial and bron-
chiolar epithelium, Clara cells, type II pneumocytes, and alveolar
macrophages from human lung have been shown to express CYP
enzymes (Hukkanen et al., 2002). Therefore, it is likely that most
of resident cells express ethanol oxidizing activity and capable of
oxidizing ethanol, but speciﬁc information on the metabolism of
ethanol in various cell types in the lung is largely lacking.
An alternative metabolism of ethanol is driven by fatty acid
ester ethyl ester (FAEE) synthase, phospholipase D, sulfatase and
glucuronidase, called as nonoxidative pathway, are also ubiqui-
tous in the mammalian lungs (Aradottir et al., 2006; Lieber, 2004;
Manautou and Carlson, 1991; Sharma et al., 1991; Zakhari, 2006).
Ethyl sulfate and ethyl glucuronide are water soluble and thus
rapidly excreted. On the other hand, phosphatidylethanol (PEt) and
FAEEs, the products of nonoxidative metabolism of ethanol cat-
alyzed by phospholipase D and FAEE synthase, respectively, are
lipophilic and have been shown to accumulate in target organs
including lungs (Aradottir et al., 2002, 2006; Bernstein et al.,
1990; Kaphalia et al., 2004; Laposata and Lange, 1986; Manautou
and Carlson, 1991). Although toxicity of nonoxidative metabo-
lites of ethanol in mammalian lungs has not been investigated,
mammalian lungs are well equipped for both oxidative and non-
oxidative metabolism of ethanol and potential target of injury by a
wide range of ethanol metabolites formed in the tissue (Fig. 1).
3. Toxicity of ethanol metabolites
Both, ADH- and CYP2E1-catalyzed oxidation of ethanol generate
a reactive metabolite acetaldehyde, which readily forms adducts
with proteins and causes oxidative stress (Das and Mukherjee,
2010; Jones, 1995; Zakhari, 2006). Oxidative metabolism of ethanol
also increases the ratio of NADH to NAD resulting in a dysregulation
of lipid metabolism (Day and Yeaman, 1994). Genetic polymor-
phisms and altered levels of ADH, ALDH and CYP2E1 proteins
inﬂuence the consumption of and susceptibility to ethanol and is
possibly involve organ-speciﬁc injuries (Yin, 1994). Once formed,eroxisomal catalase to acetaldehyde in both the liver and in lungs
Bernstein et al., 1990; Jones, 1995; Rikans and Gonzalez, 1990;
in et al., 1992). CYP2E1 is particularly induced during chronic
lcohol abuse and is shown to be responsible for production of
eactive oxygen species (Lieber, 2004). However, catalase may  notacetaldehyde is rapidly absorbed through the lungs (NIAAA, 2000).
Biological consequences of acetaldehyde exposure include reduced
phagocytotic index of lung macrophages and degeneration of the
nasal olfactory epithelium (Appelman et al., 1986; Wyatt et al.,
2012). Malondialdehyde (MDA, lipid peroxidation products) and
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temic oxidative stress (Rahman and MacNee, 1996). Oxidation of
alcohol to acetaldehyde catalyzed by ADH and/or CYP2E1 (Fig. 1)
generates ROS such as superoxide anion (O2•−), the hydroxyl (•OH),
and 1-hydroxyethyl (C2H5O•) radicals (Cederbaum, 2010). Suchig. 1. Alcohol metabolism and putative mechanism of alcoholic lung injury. The 
eferences to color in this ﬁgure legend, the reader is referred to the web  version of
cetaldehyde (MAA)-adducted proteins formed in the lungs of mice
fter co-exposure of cigarette smoke and alcohol are shown to
timulate bronchial epithelial cell interleukin-8 (IL-8) production
ia the activation of proteins kinase C epsilon. Proinﬂammatory
esponses of MAA-adducted proteins in vitro indicates that lung
urfactant proteins are biologically relevant targets for MDA  and
cetaldehyde adduction (Wyatt et al., 2012).
FAEEs are shown to be formed in the lungs of rats and rabbits
Manautou and Carlson, 1991). These esters are reported to be
ytotoxic to cells in culture and cause pancreatic toxicity in rats
dministered FAEEs (Werner et al., 1997; Wu  et al., 2006). How-
ver, to the best of our knowledge, the pulmonary toxicity of FAEEs
n vitro or in vivo has not been investigated. Another prominent
onoxidative metabolite of ethanol reportedly present in the lungs
f alcoholics is PEt (Alling et al., 2005). Therefore, an evaluation of
ung toxicity of FAEEs and PEt is warranted.
. Lungs as target of alcohol-induced oxidative stress
Oxidative stress is thought to be a central feature of alcohol over-
onsumption-associated tissue injury and mechanism of alcoholic
ung disease and several other diseases (Halliwell, 1996; Heffner
nd Repine, 1989). Therefore, understanding the role of oxidative
tress in the pathophysiology of alcoholic lung disease is important
or devising therapeutic approaches to reverse the disease progres-
ion.
Among the organ systems, mammalian lungs are a potential tar-
et of oxidative stress resulting from chronic alcohol abuse due
o their direct exposure to toxic environmental pollutants, smoke,
nd other particulate matter present in the ambient air. Alcohol
s a well-recognized systemic toxin and its oxidative metabolism
o acetaldehyde generates a series of ROS and free radicals,
hich decreases the system’s ability to detoxify the ROS gener-
ted reactive intermediates or their products (Cederbaum, 2010).
OS-induced reactions develop an imbalance between oxidantical pathway for ethanol metabolism is shown in green. (For interpretation of the
rticle.)
production and system’s ability to detoxify the ROS generated reac-
tive intermediates and products (Fig. 2). Reduced glutathione (GSH)
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adicals can damage cellular proteins, lipids and DNA through oxi-
ation reactions most importantly via peroxidation of unsaturated
atty acids. A signiﬁcant amount of ethanol metabolized oxidatively
n the lungs can be excreted in exhaled breath by volatilization
cross the alveolar–capillary membrane interface. However, local
lcohol metabolism within the lung may  be sufﬁcient to exert sig-
iﬁcant oxidative stress in view of an increased ratio of oxidized to
educed GSH in lung lavage ﬂuid, as has been reported in alcohol-
ed animals and alcohol abusers (Holguin et al., 1998; Moss et al.,
000). An altered redox state associated with increased production
f ROS may  damage lungs through ethanol-associated oxidation of
ellular proteins, lipids and DNA. ROS and their products with cel-
ular proteins, lipids and DNA can also act as cellular messengers
n redox signaling pathways and may  have far reaching adverse
ystemic consequences.
. Oxidative stress and ARDS and COPD
Epidemiological studies reveal that oxidative stress is an impor-
ant risk factor in the etiology of ARDS and COPD (MacNee, 2001;
oss et al., 1996). Often oxidative stress is linked with the oxi-
ation of proteins, lipids and DNA to form oxidized proteins,
ipid aldehydes and peroxides such as malondialdehyde (MDA),
exanals and 4-hydroxynenonal (4-HNE), and 8-hydroxy-deoxy-
uanosine, which disrupt normal signaling events required for
omeostasis and cause cell injury. Therefore, establishing a cause
nd effect interrelationship between toxicity and oxidative stress
y assessing oxidized proteins, lipids or DNA could provide a better
nderstanding of lung injury. However, ROS-derived reactions with
ndogenous biomolecules are often complex and multifaceted,
esulting in the generation of secondary and tertiary reactive prod-
cts and causing dimerization and polymerization between and
mong the radicals and adducts. These reactions are driven by sig-
iﬁcant change in redox status such as increased NADH/NAD ratio,
p-regulation of NADH oxidase, and depletion of reduced GSH via
ts de novo synthesis and/or increased oxidation and a compro-
ised antioxidant system (Aytacoglu et al., 2006; Polikandriotis
t al., 2006; Yeh et al., 2007; Yeligar et al., 2012). Such conditions
ften compromise immunity and cause increased susceptibility to
nfection in lungs (Moss et al., 1996).
. Antioxidants
Although the interrelationship between oxidative stress and
ntioxidants is not fully explored in alcoholic lung injury, reduced
SH appears to be a determining factor in human and experimen-
al models of alcoholic lung disease (Guidot and Roman, 2002). To
aintain normal physiological redox status, GSH, which is syn-
hesized primarily in the liver, is circulated to all other organs
ncluding the lungs. Chronic alcohol ingestion depletes reduced
SH within the alveolar space by as much as 80–90%, and, con-
equently impairs alveolar epithelial surfactant production and
arrier integrity, decreases alveolar macrophage function, and
ncreases lung susceptibility to oxidant-mediated injury. Alcohol
dministration also increases glutathione turnover, a process inde-
endent of glutathione oxidation, glutathione S-transferase (GST)
nd glutathione peroxidase (GPX) activities. Precisely how alcohol
ecreases GSH levels in the lung are not well understood.
. Alcohol abuse and endoplasmic reticulum (ER) stress in
ungsAs discussed earlier alcohol abuse is a signiﬁcant risk factor
or ARDS and COPD. Studies into the etiology of lung diseases like
OPD and idiopathic lung ﬁbrosis indicate a role for ER stress and Letters 222 (2013) 171– 179
unfolded protein response (UPR) pathways in their pathogenesis
(Greene and McElvaney, 2010; Malhotra and Kaufman, 2007). How-
ever, scant literature exists regarding ER stress in lungs during
chronic alcohol abuse.
In addition to its key role in the synthesis of proteins and in
xenobiotic metabolism, another important role of ER is to correctly
fold proteins and modify their tertiary and quaternary structures
or direct misfolded proteins to ER associated degradation (ERAD)
(Ji, 2012). Accumulation of misfolded proteins in the lumen of ER
membrane causes ER stress, which activates the UPR  to correctly
fold unfolded proteins or remove the damaged cells by apopto-
sis. The UPR corrects ER stress through attenuating general protein
synthesis and translation, by increasing protein folding capacity,
and by expediting the degradative process of misfolded proteins (Ji
et al., 2011).
A variety of pathological conditions (oxidative stress, hypoxia
or altered calcium homeostasis, glucose starvation, and infections)
or chemical exposure can result in ER stress. Glucose-regulated
protein (GRP) 78 and other-prosurvival ER chaperones that con-
trol stress signaling pathways in the ER membrane are activated
by ER stress. When cells undergo ER stress, the UPR is activated
by three resident sensors: (i) protein kinase-like ER kinase (PERK);
(ii), inositol-requiring enzyme (IRE)-1;  and (iii) activating tran-
scription factor 6 (ATF6) (Ji, 2012). Studies of chronic inﬂammatory
lung diseases (bronchial asthma, COPD, and cystic ﬁbrosis) as well
as data from our laboratory show increasing evidence of ER stress
in ethanol-induced lung injury (Greene and McElvaney, 2010;
Kaphalia and Calhoun, 2012; Kaphalia et al., 2013). Earlier, Shang
et al. reported activation of the ER stress pathways in the lungs of
lipopolysaccharide (LPS)-treated mice (Shang et al., 2011). ER stress
has been reported in the lungs of patients with familial and spo-
radic idiopathic pulmonary ﬁbrosis, and produces a dysfunctional
epithelial cell phenotype, facilitating ﬁbrotic remodeling (Lawson
et al., 2011). Cigarette smoke (CS) can also cause ER stress in the
lungs of patients with COPD (Kelsen et al., 2008). Lung epithelial
cells treated with CS extract induce ER stress and apoptosis (Tagawa
et al., 2008). Impaired or inhibited proteasomal activity disrupts
ERAD and causes accumulation of misfolded proteins resulting in
ER stress (Chauhan et al., 2008; Kardosh et al., 2008). Therefore, ER
stress appears to be a common pathological condition in various
lung diseases caused by exposure to CS and inhaled environmen-
tal pollutants. Further studies to elucidate the role of ER stress and
UPR in pathogenesis of alcohol abuse-related lung injury could thus
lead to a better understanding of the mechanism(s) of alcoholic lung
disease.
Recently, we  found that primary bronchial smooth muscles cells
treated with bronchial lavage ﬂuid from severe asthmatic patients
cause ER stress (Kaphalia and Calhoun, 2012). In other study, we
found an up-regulation of ATF6 and PERK and/or their downstream
signaling in the lungs of hepatic ADH-deﬁcient mice fed ethanol
daily for 3 months (Kaphalia et al., 2013). In these studies, we
found activation of XBP1, protein disulﬁde isomerase (PDI) and
C/EBP homologous protein (CHOP) suggesting a role of ER stress in
ethanol-induced lung injury. It is likely that a prolonged ER stress
also contribute to the etiologies of chronic diseases. Since very little
is known about ER stress in the lungs of alcohol abusers, under-
standing the role of ER stress in alcoholic lung disease could be
useful for developing preventive measures at molecular levels.
8. Alcohol abuse and immunosuppression of respiratory
tractThe respiratory tract has a sophisticated immune defense
mechanism that effectively protects lungs from chemical insults,
and from bacterial or viral infections. However, excess alcohol
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onsumption suppresses the immune defense network and predis-
oses the respiratory tract to a range of infections (Macgregor and
oubia, 1997). Reduced innate and adaptive immunity may be an
mportant co-morbidity in alcoholic patients, as the mortality rate
lone from pneumonia is more than double in alcoholics compared
ith non-alcoholics (Capps and Coleman, 1923). Because of their
irect exposure to the environment, host immunity expressed in
he lungs is critically important to survival, and when impaired, the
ungs become potential targets of pneumonia related to bacterial
nd viral infections.
.1. Innate immunity
Major components of non-speciﬁc host defense include struc-
ural airway barriers that prevent entry of pathogens into the
espiratory tract, and the mucociliary lining in the surface of air-
ays, pathogen killing mechanisms such as the production of
ntimicrobial peptides, ROS, hypochlorous acid, and phagocytic
efense by polymorphonuclear leukocytes (PMNs or neutrophils)
nd alveolar macrophages. Acute and chronic alcohol intoxication
nterferes with the innate response at structural and barrier lev-
ls causing leakiness between the physical barriers and mucosal
rgans, increased lung permeability due compromised tight junc-
ions between the epithelial cells, and reduced cell mediated host
efense mechanisms.
The cell mediated arm of innate immunity is primar-
ly controlled by granulocytes (leukocytes or PMNs), mono-
ytes/macrophages, dendritic cells and natural killer (NK) cells.
eutrophils are the most abundant type of PMNs in the lungs.
oth chronic alcohol abuse and experimental acute and chronic
lcohol ingestion inhibit pulmonary recruitment of PMNs and
heir functions, resulting in increased susceptibility to bacterial
nfections, and impaired bacterial clearance, in turn resulting in
n increased incidence of lung diseases and related mortality
Zhang et al., 2002b). Alcohol-mediated effects range from the
nitial stages of primitive hematopoietic precursor commitment
o impaired recruitment of PMNs, their adherence to endothelial
ells and production of superoxide, elastase and nitric oxide syn-
hase (Greenberg et al., 1999; Macgregor et al., 1988; Siggins et al.,
011; Stoltz et al., 1999; Vander Top et al., 2006). Alcohol ingestion
nterferes with differentiation and impairs phagocytic functions of
lveolar macrophages (Bermudez and Young, 1991; Dannenberg,
989; Laso et al., 2007; Lau et al., 2009; Siggins et al., 2009; Szabo
t al., 2004).
The nature of immune responses and immune cell trafﬁc-
ing are controlled by cytokines and chemokines, respectively,
lthough functional overlap exists. Alcohol predisposes the host
o a variety of complications including an inability to produce
mportant activating and chemotactic cytokines, and lung innate
mmunity by altering the expression of proinﬂammatory media-
ors. Alcohol-mediated suppression of pro-inﬂammatory cytokines
TNF and IL-1) and chemokines (CINC and MIP-2) and induction
f anti-inﬂammatory cytokines (IL-10) could be associated with an
mpaired host defense against infection, or an altered resolution of
nﬂammation (Boe et al., 2003; Mandrekar et al., 1999; Standiford
nd Danforth, 1997; Stoltz et al., 2000; Zisman et al., 1998).
Granulocyte colony stimulating factor (G-CSF) and granulocyte
acrophage colony stimulating factor (GM-CSF), growth factors
nvolved in the production or differentiation of granulocytes and
ranulopoietic response are also signiﬁcantly reduced after ethanol
xposure (Basu et al., 2002; Joshi et al., 2005, 2006; Zhang et al.,
005). Given the key role of neutrophils in host defense against bac-
erial infections, this ﬁnding is of great potential clinical relevance
n alcohol-related pneumonias.
Interferons (IFNs) secreted from host cells in response to the
resence of pathogens, particularly viruses, trigger protectiveFig. 3. Schematic illustration by which alcohol abuse increases the risk of pulmonary
infection by impairing the innate and adaptive immunity.
immune defense and interfere with viral replications. Alcohol
ingestion in humans and rodents causes reduced secretion of IFNs
and contributes to an increased risk of bacterial and viral infec-
tions (Starkenburg et al., 2001; Szabo et al., 2001). The lungs of
alcohol-fed rodents infected with Klebsiella pneumoniae showed a
decreased and delayed production of IFN- mRNA and related pro-
teins resulting in reduced bacterial clearance from the lungs and
reduced survival of the animals (Zisman et al., 1998).
Finally, the complement system is also affected by alcohol
exposure. The complements system refers to a series of pro-
teins circulating in the blood in an inactive form, but become
sequentially activated in response to the recognition of molecu-
lar components of microorganisms. Once activated, complements
cover the surface of the pathogen to be recognized for the phagocy-
tosis. Chronic alcoholic patients express abnormally low levels of
complements precursors in the circulation (Bhopale et al., 2011).
Further, some studies have also reported reduced activation of the
complements after chronic alcohol exposure (Bykov et al., 2007;
Roychowdhury et al., 2009). Either of these abnormalities could
impair complement-dependent host defense.
Therefore, a better understanding of the mechanisms by which
ethanol and its metabolites regulate the expression and function
of transcription factors and inﬂammatory mediators is needed.
Many proofs of concept experiments could be evaluated using pri-
mary cell culture and animal models exposed to ethanol compared
to its oxidative and non oxidative metabolites. Moreover, alcohol
metabolites can also act as triggers for airway disease exacerbations
especially in atopic asthmatics and in Asian populations who are
known to have a reduced capacity to metabolize alcohol. Therefore,
epidemiological studies in larger cohorts would improve under-
standing of the effects of chronic alcohol abuse and metabolites of
ethanol on the complement system.
8.2. Adaptive immunity
Cell mediated adaptive immunity is another important aspect of
host defense which can be impaired by alcohol and its metabolites
(Fig. 3). A pathogen encounter results in dendritic cell processing
and antigen presentation, which then activates and differentiates
T-cells into different subtypes such as T-helper cells (Th1, 2 and 17;
characterized by surface expression of CD4+) and cytotoxic T-cells,
characterized by expression of CD8+ and contain powerful enzymes
for inducing the death of infected cells. Finally, interplay between
the B-cells and T-cells is required for optimal immune responses to
counteract the invasion of most the pathogens.








































lFig. 4. Lung injury targets in chronic a
Acute and chronic alcohol ingestion can interfere with anti-
en presentation required to activate T- and B-cells and can also
arkedly affect the differentiation of dendritic cells (Ness et al.,
008). A signiﬁcant reduction in absolute numbers of CD4+ T lym-
hocytes has been reported in chronic alcoholics (Saad and Jerrells,
991). Generally, lymphocyte proliferative responses to speciﬁc
ntibodies against T-cell receptors are blunted by alcohol (Domiati-
aad and Jerrells, 1993). In alcoholics, a diminished capacity of T
ymphocytes to produce IFN-, an important cytokine that stimu-
ates cell-mediated immunity has been reported (Chadha et al.,
991). In addition, alcohol consumption can also suppress the
ecruitment of CD4+ and CD8+ T lymphocytes in response to Pneu-
ocystis carinii infection in the lungs (Shellito and Olariu, 1998). T
ells isolated from chronic alcoholics and ethanol-intoxicated ani-
als possess a decreased response to mitogen stimulation and an
mpaired hypersensitivity responses (Lundy et al., 1975; Spinozzi
t al., 1991). Animal studies of pulmonary tuberculosis have shown
ecreased lung CD4+ and CD8+ T cells and diminished proliferation
n ethanol-fed mice (Mason et al., 2004).
Pulmonary host defense against bacterial pathogens is depend-
nt on intact type-1 T-cell immunity (Greenberger et al., 1996;
oore et al., 2002). Discovery of the T-cell cytokine IL-17 is impor-
ant because it serves as a link between adaptive and innate
mmunity upregulating chemokines and cytokines to promote
eutrophilic inﬂammation. Animals inoculated with K. pneu-
oniae exhibit induced expression of pulmonary IL-17 within
2 h, and animals deﬁcient in the receptor for IL-17display
n increased mortality from infection with this pathogen (Ye
t al., 2001). Chronic alcohol intoxication inhibits the pulmonary
L-17 response to K. pneumoniae infection, and shows a dose-
ependent inhibition of IL-17 by ethanol after in vitro stimulation
f T cells (Shellito et al., 2001). Therefore, induction of IL-17
ytokine can improve survival of alcohol-treated animals (Ye et al.,
001).
Despite the decreases in B cell numbers, alcoholics with liver
isease have increased levels of circulating nonprotective IgA,
gM, and IgG. In contrast, bronchoalveolar lavage (BAL) ﬂuid
n patients with alcoholic liver disease exhibits reduced lev-
ls of total IgG and IgG1 (Spinozzi et al., 1992). This defect
losely correlates with the development of bacterial pneumonia.
eplacement of immunoglobulin therapy partially restores BAL Ig
evels and decreases the rate of subsequent pulmonary infection,lic abuse and therapeutic approaches.
further supporting the importance of airway antibodies in host
defense.
9. Approaches for treatment of alcoholic lung disease
Most therapeutic efforts directed toward alcoholic lung dis-
ease are based upon the use of direct antioxidants such as
N-acetylcysteine (NAC) and GSH. As a precursor of cysteine needed
for the synthesis of GSH, NAC acts as indirect antioxidant. There-
fore, restoring GSH homeostasis in the lung by GSH replenishment
or by enhancing its endogenous synthesis has therapeutic poten-
tial for treating chronic alcoholic lung disease. Such an approach
can also restore antioxidant enzymes (e.g., glutathione reductase
and superoxide dismutase).
In animals, dietary GSH supplementation is effective in main-
taining GSH homeostasis, but it requires chronic GSH ingestion to
prevent oxidative damage (Guidot and Brown, 2000; Guidot et al.,
2000; Holguin et al., 1998). Dietary supplementation of GSH pre-
cursors can also restore both the mitochondrial and cytosolic GSH
pool, as well as alveolar epithelial functions and can signiﬁcantly
decrease the risk of alcoholic lung injury (Guidot and Brown, 2000).
Therefore, adequate GSH precursor supplementation, which might
signiﬁcantly decrease risk of alcoholic lung injury and possibly even
pneumonia, should be a better therapeutic approach.
An association of the D/D genotype of the angiotensin con-
verting enzyme (ACE) I/D polymorphism with phagocytic NADPH
oxidase-mediated superoxide overproduction has been reported
(Jose et al., 2009). The observation suggests that the mechanisms
that control the angiotensin pathway are linked to the develop-
ment of oxidative stress and potentially oxidative injury. Thus
not surprisingly ACE II have been shown to signiﬁcantly decrease
the pulmonary complications due to alcohol abuse (Bechara et al.,
2003). Therefore, ACE II inhibitors as well as AT1 receptor blockers
could potentially be employed to prevent the alcoholic lung phe-
notype. (Fig. 4), G-CSF enhances pulmonary clearance of bacteria
from ethanol treated rats and improves their survival including the
expression of adhesion molecules and phagocytosis (Stoltz et al.,
1999; Zhang et al., 1999). Rats fed G-CSF (50 g/kg) twice daily for
2 d can increase circulating PMN’s within the alveolar space by 5-
to 7-folds (Zhang et al., 1999). In a clinical trial of 746 patients, sub-
cutaneous injection of G-CSF (300 g/day) for up to 10 d increased



























































aL. Kaphalia, W.J. Calhoun / Tox
RDS and disseminated intravascular coagulation (Nelson et al.,
998). Therefore, for alcoholic lung diseases, enhancing the chemo-
actic signals using G-CSF can enhance recruitment of circulating
MNs into the alveolar space.
Expressions of the GM-CSF receptor, alveolar epithelial bar-
ier function and ﬂuid transport are signiﬁcantly reduced in rats
ed ethanol (Joshi et al., 2005; Mandujano et al., 1995). These
xpressions can be restored by intrapulmonary administration
f recombinant GM-CSF, which improves functional activities of
lveolar macrophages in alcohol-fed rats and restores alveolar
pithelial barrier function damaged by alcohol ingestion (Pelaez
t al., 2004).
GM-CSF therapy can reduce the intensity of pulmonary P. carinii
nfection associated with enhanced alveolar macrophage TNF pro-
uction in CD4 depleted mice (Paine et al., 2000). Infusion of
M-CSF at a dose of 125 g/m2 for 72 h causes up-regulation of
D11b expression on circulating PMNs and a more frequent reso-
ution of infection in patients (Rosenbloom et al., 2005). In a clinical
rial of 1200 neutropenic patients with pneumonia, a daily admin-
stration of GM-CSF (mean dose of 5 g/kg daily) for a mean period
f 13 d restored blood leukocyte counts (Dierdorf et al., 1997).
ematopoietic recovery was also observed in 74% of the patients
ith a good clinical and/or radiologic improvement. Therefore,
M-CSF therapy can be beneﬁcial for alcoholic patients. However,
igher GM-CSF daily doses (i.e., >15 g/kg) are associated with seri-
us side effects such as generalized inﬂammation and tissue injury
Arning et al., 1991).
Macrophages stimulated by IFN- are capable of killing over
 dozen different pathogens (Murray, 1994). IFN- administered
long with antibiotics produces synergistic effects in the treat-
ent of certain pulmonary infections. Intratracheal instillation
f IFN- or its aerosol inhalation activates alveolar macrophages
hat enhance the lung microbicidal activities (Beck et al., 1991;
affe et al., 1991). Local or systemic administration of IFN- alle-
iates alcohol-induced suppression of MIP-2 and CINC production
n the lung following intrapulmonary LPS challenge. Interestingly,
atients with multidrug resistant tuberculosis treated with IFN-
apidly clear the infection and eradicate the mycobacteria (Condos
t al., 1997; Gallin et al., 1995).
Whether any particular long term therapeutic strategy will be
ffective for either alcoholic lung disease, ARDS or COPD cannot be
redicted with certainty. Combination therapies including antibi-
tics will be required to treat acute and chronic lung injuries.
hough dietary supplementation with GSH precursors or selective
nhibition of ACE II and/or AT receptors can limit lung injury in
nimal models, G-CSF appears to be most attractive candidate for
reating the alcoholic lung disease as well as for ARDS and COPD.
0. Conclusions
Alcoholic lung disease is a signiﬁcant public health concern and
nderstanding its mechanism should enable us to develop effective
herapeutic intervention and treatment. Immunosuppression due
o acute or chronic alcohol abuse appears to be a signiﬁcant risk fac-
or in the initiation and progression of ARDS and COPD. Impaired
lveolar epithelial barrier functions, mucocilliary clearance and
M-CSF signaling, and increased renin angiotensin activity are the
ajor effects of acute and chronic alcohol abuse. A dramatic deple-
ion of reduced glutathione in the lungs of ethanol fed animals
s a hallmark of the prevailing oxidative stress. Therefore, oxida-
ive metabolism of ethanol and its associated oxidative stress have
een suggested as underlying mechanisms of alcoholic lung dis-
ase. ER stress and UPR signaling in COPD and lung ﬁbrosis have
lso been reported. Therefore, ER stress and oxidative stress, both
ssociated with ethanol abuse, could be critical factors for the Letters 222 (2013) 171– 179 177
suppression of innate and adaptive immunity in the lungs, as is
reported in ARDS and COPD. In view of the metabolic basis of
alcoholic lung diseases, studies investigating the role of nonoxida-
tive metabolites of ethanol such as FAEEs and PEt are warranted.
Although not discussed in this review, discovery driven approaches
such as metabolomics and proteomics could be utilized to identify
molecular pathways of disease, so as to develop biomarker candi-
dates in alcoholic lung disease. Previous therapeutic studies have
largely addressed replenishing reduced GSH levels or administer-
ing GM-CSF. However, treating immunosuppressive disease related
to ethanol abuse becomes even more challenging because the tar-
gets are multiple and no biomarkers are yet identiﬁed. Therefore,
understanding the mechanism of immunosuppresion by ethanol
oxidative metabolites in conjunction with ER stress could open new
avenues to identify therapeutic targets for alcoholic lung disease.
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